Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
It is better to be in a clinical trial than not: lessons learnt from clinical neurology--the management of acute multiple sclerosis relapses.
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
Ono to enter license agreements with Merck KGaA
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.
Potassium-Retaining Diuretics: Amiloride
Increased axonal expression of nectin-1 in multiple sclerosis plaques.
Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.
Pelvic Floor Muscle Training With and Without Electrical Stimulation in the Treatment of Lower Urinary Tract Symptoms in Women With Multiple Sclerosis.
Genzyme’s Lemtrada™ approved in Australia for treatment of multiple sclerosis
[Infections and fingolimod].
[Plasmapheresis in central nervous system disorders].
Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome.
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease.
Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.
Treatment of multiple sclerosis with anti-CD20 antibodies.
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair.
Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection-a case report.
Pages
« first
‹ previous
…
95
96
97
98
99
100
101
102
103
…
next ›
last »